Variations in the management of diabetic ketoacidosis in children

J A Edge1, D B Dunger

  • 1Department of Paediatrics, John Radcliffe Hospital, Oxford, UK.

Insights

Cerebral edema in children treated for diabetic ketoacidosis is a serious concern. Protocols using more aggressive fluid resuscitation and specific saline types were linked to higher incidences of this complication.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Neurology

Background:

  • Cerebral edema is a significant complication in pediatric diabetic ketoacidosis (DKA).
  • Variations in DKA management protocols may influence the occurrence of cerebral edema.
  • Understanding these variations is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the relationship between fluid, bicarbonate, insulin, and potassium management strategies in DKA and the incidence of cerebral edema in UK pediatric centers.
  • To identify specific treatment variations associated with recalled cases of cerebral edema.

Main Methods:

  • A survey of 25 UK centers examining their DKA management protocols.
  • Correlation of fluid resuscitation volumes, fluid types (0.9% saline, 0.45% saline), rehydration periods, and potassium administration with reported cerebral edema incidence.
  • Comparison of protocols between centers that recalled cerebral edema cases and those that did not.

Main Results:

  • Protocols associated with cerebral edema utilized more plasma for resuscitation (22 vs. 18 ml/kg) and larger maintenance fluid volumes for children aged 6-9 years (81 vs. 70 ml/kg/day).
  • Centers reporting cerebral edema were more likely to switch to 0.18% saline after initial glucose reduction compared to those without reported cases (8/8 vs. 5/10).
  • Free water overload is suggested as a potential contributing factor to cerebral edema.

Conclusions:

  • Specific fluid management strategies, including aggressive resuscitation and certain saline types, may increase the risk of cerebral edema in pediatric DKA.
  • Further research into optimal fluid management is warranted to minimize this life-threatening complication.
  • Standardizing DKA treatment protocols could potentially reduce the incidence of cerebral edema.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...